Boston Megan 4
4 · Benitec Biopharma Inc. · Filed Mar 8, 2024
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2024-03-06+200,004→ 200,004 totalExercise: $5.21Exp: 2034-03-06→ Common Stock (200,004 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027.